Karin Johnson, MD, says permanent daylight saving time won’t boost exercise or road safety and that sleep loss from spring ...
Nikhil C. Munshi, MD, says 25% to 30% of patients with myeloma may now be cured, but relapse and access remain challenges.
Mayo Clinic case-control study links higher birth weight and childhood obesity to greater non-Hodgkin lymphoma risk, while ...
Cleveland Clinic's Beth Faiman, PhD, MSN, says fast-moving myeloma care requires funded education and fewer barriers for ...
Participating insurers reduced prior authorization requirements by 11% overall, equating to approximately 6.5 million fewer requests, with Medicare Advantage experiencing a greater than 15% reduction.
AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, ...
Home-based oncology transforms practice transformation with clear bagging, protecting Medicare reimbursement, provider ...
PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know ...
Kidney Week 2026 brought strong IgAN data, looked back on 5 years of value-based kidney care, and highlighted evidence of ...
UChicago Medicine’s Obada Shamaa, MD, PhD, discusses why bronchiectasis is underrecognized and how to personalize airway ...
A clinical-note analysis of more than 1000 patients found rising off-label BPC-157 use for pain and healing, with outcomes ...
Meta-analysis suggests off-label upadacitinib drives major alopecia areata hair regrowth and SALT score gains, but phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results